Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Depression and treatment with anti‐calcitonin gene related peptide (CGRP) (ligand or receptor) antibodies for migraine
Simone de Vries Lentsch, Britt W. H. van der Arend, Irene de Boer, et al.
European Journal of Neurology (2023) Vol. 31, Iss. 2
Open Access | Times Cited: 13

Showing 13 citing articles:

Migraine Comorbidities
Dan Iulian Cuciureanu, Cătălina Elena Bistriceanu, Georgiana-Anca Vulpoi, et al.
Life (2024) Vol. 14, Iss. 1, pp. 74-74
Open Access | Times Cited: 11
Understanding the Biological Relationship between Migraine and Depression
Adrián Viudez‐Martínez, Abraham B. Torregrosa, Francisco Navarrete, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 163-163
Open Access | Times Cited: 9
Proinflammatory cytokines and neuropeptides in psoriasis, depression, and anxiety
Emily Keenan, Richard D. Granstein
Acta Physiologica (2025) Vol. 241, Iss. 3
Open Access | Times Cited: 1
Three-year treatment with anti-CGRP monoclonal antibodies modifies migraine course: the prospective, multicenter I-GRAINE study
Piero Barbanti, Cinzia Aurilia, Paola Torelli, et al.
Journal of Neurology (2025) Vol. 272, Iss. 2
Open Access
The effect of calcitonin gene-related peptide monoclonal antibodies on restless legs syndrome in patients with migraine
Keisuke Suzuki, Shiho Suzuki, Hiroaki Fujita, et al.
The Journal of Headache and Pain (2025) Vol. 26, Iss. 1
Open Access
Research Status on the Pathogenesis of Migraine
宇宸 张
Advances in Clinical Medicine (2025) Vol. 15, Iss. 02, pp. 798-805
Closed Access
Comorbidities in migraine
Gianluca Coppola, Gabriele Sebastianelli, Francesco Casillo, et al.
Elsevier eBooks (2024), pp. 61-79
Closed Access | Times Cited: 3
Resistant and refractory migraine – two different entities with different comorbidities? Results from the REFINE study
Carine Rosignoli, Raffaele Ornello, Valeria Caponnetto, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Manual trigger point treatment in migraine management: a scope review
Roberto Tedeschi
Confinia Cephalalgica (2024) Vol. 34, Iss. 2
Closed Access | Times Cited: 1
Safety of Rimegepant in Adults with Migraine and Anxiety, Depression, or Using Antidepressants: Analysis of a Multicenter, Long-Term, Open-Label Study
David Kudrow, Susan Hutchinson, Glenn C. Pixton, et al.
Pain and Therapy (2024)
Open Access
Switching from ligand to receptor anti‐calcitonin gene‐related peptide (CGRP) antibodies or vice versa in non‐responders: A controlled cohort study
Nancy van Veelen, Britt W. H. van der Arend, E. Hiele, et al.
European Journal of Neurology (2024)
Open Access
Migraines and Mood Disorders: A Case of Hospitalization for Depression and Mania After Eptinezumab-jjmr Infusion
Vincent Fryer, David Hernández, Shahid A Qaudeer, et al.
American Journal of Psychiatry Residents Journal (2024) Vol. 20, Iss. 2, pp. 6-8
Open Access
Page 1

Scroll to top